| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |